Patents by Inventor Xiaoxiao Yang

Xiaoxiao Yang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250163091
    Abstract: New derivatives of human milk oligosaccharides and methods for preparing them are disclosed. Also described herein are hST6GALNAC V and hGCNT2-B variants, along with polynucleotides encoding the variants and host cells comprising the polynucleotides. Further provided herein are reaction mixtures comprising the hST6GALNAC V and hGCNT2-B variants.
    Type: Application
    Filed: January 19, 2023
    Publication date: May 22, 2025
    Inventors: Xi CHEN, Yuanyuan BAI, Hai YU, Libo ZHANG, Xiaoxiao YANG
  • Publication number: 20250011292
    Abstract: Novel rhodanine derivatives and methods for their use are provided herein. The rhodanine derivatives are useful in treating or preventing viral infections, including coronavirus infections (e.g., a SARS-CoV-2 virus infection). The rhodanine derivatives are also useful as photosensitizers for photodynamic therapy in treating or preventing cancer in a subject.
    Type: Application
    Filed: October 12, 2022
    Publication date: January 9, 2025
    Applicant: GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC.
    Inventors: Binghe WANG, Xiaoxiao Yang, Ming Luo, Mukesh Kumar
  • Publication number: 20240391886
    Abstract: The present invention provides new compounds and compositions thereof that release carbon monoxide for the treatment of medical disorders that are responsive to carbon monoxide, for example, inflammatory, pain, and dermatological disorders.
    Type: Application
    Filed: July 11, 2024
    Publication date: November 28, 2024
    Applicant: Georgia State University Research Foundation, Inc.
    Inventors: Binghe Wang, Xingyue Ji, Ladie Kimberly De La Cruz, Xiaoxiao Yang
  • Patent number: 12071415
    Abstract: The present invention provides new compounds and compositions thereof that release carbon monoxide for the treatment of medical disorders that are responsive to carbon monoxide, for example, inflammatory, pain, and dermatological disorders.
    Type: Grant
    Filed: April 16, 2021
    Date of Patent: August 27, 2024
    Assignee: GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC.
    Inventors: Binghe Wang, Xingyue Ji, Ladie Kimberly de la Cruz, Xiaoxiao Yang
  • Patent number: 11713350
    Abstract: The present invention relates to a medicine for treating disorders of glucose and/or lipid metabolism. This invention demonstrates a new therapeutic target for treatment of glucose and/or lipid metabolic disorders. The invention further provides a method of treating glucose and/or lipid metabolic disorders, administering to a subject comprising a Nogo-B inhibitor, thereby treating the glucose and/or lipid metabolic disorders.
    Type: Grant
    Filed: August 12, 2020
    Date of Patent: August 1, 2023
    Assignee: Hefei University of Technology
    Inventors: Jihong Han, Yajun Duan, Shuang Zhang, Xiaoxiao Yang, Yuanli Chen
  • Publication number: 20210238155
    Abstract: The present invention provides new compounds and compositions thereof that release carbon monoxide for the treatment of medical disorders that are responsive to carbon monoxide, for example, inflammatory, pain, and dermatological disorders.
    Type: Application
    Filed: April 16, 2021
    Publication date: August 5, 2021
    Applicant: Georgia State University Research Foundation, Inc.
    Inventors: Binghe Wang, Xingyue Ji, Ladie Kim De La Cruz, Xiaoxiao Yang
  • Publication number: 20210087262
    Abstract: The present invention relates to a medicine for treating disorders of glucose and/or lipid metabolism. This invention demonstrates a new therapeutic target for treatment of glucose and/or lipid metabolic disorders. The invention further provides a method of treating glucose and/or lipid metabolic disorders, administering to a subject comprising a Nogo-B inhibitor, thereby treating the glucose and/or lipid metabolic disorders.
    Type: Application
    Filed: August 12, 2020
    Publication date: March 25, 2021
    Inventors: Jihong Han, Yajun Duan, Shuang Zhang, Xiaoxiao Yang, Yuanli Chen